Department of Biochemistry University of Oxford Department of Biochemistry
University of Oxford
South Parks Road
Oxford OX1 3QU

Tel: +44 (0)1865 613200
Fax: +44 (0)1865 613201
Anaphase bridges in fission yeast cells
Whitby lab
Lactose permease represented using bending cylinders in Bendix software
Caroline Dahl, Sansom lab
Epithelial cells in C. elegans showing a seam cell that failed to undergo cytokinesis
Serena Ding, Woollard lab
Collage of Drosophila third instar larva optic lobe
Lu Yang, Davis lab
First year Biochemistry students at a practical class
Image showing the global movement of lipids in a model planar membrane
Matthieu Chavent, Sansom lab
Bootstrap Slider

Funding success for the Biochemistry solution-state NMR facility

Group leaders in the Departments of Biochemistry (Profs Christina Redfield, Jason Schnell and John Vakonakis) and Chemistry (Profs. Andy Baldwin and Tim Claridge) have secured support towards upgrading the flagship 950 MHz nuclear magnetic resonance (NMR) spectrometer, housed in Biochemistry. Funding of close to £500K has been obtained from the Engineering and Physical Sciences Research Council (EPSRC) under the “Very- and Ultra-High field NMR for the physical and life sciences” initiative. The 950 MHz NMR upgrade will include a high-sensitivity 5mm TCI “CryoProbe” and an automated sample changer. This new probe will increase 1H signal-to-noise by a factor of up to 3, allowing more challenging macromolecular systems to be studied. The sample changer will improve throughput by enabling fully automated, round-the-clock data collection. Once upgraded, time on the 950 MHz NMR spectrometer will also be made available to external users from other UK academic institutions and from industry. 

950 MHz NMR Spectrometer

950 MHz NMR Spectrometer
(Click to Enlarge)

The 22.3T Oxford Instruments magnet, which, alongside a custom-built electronics control console and probe, formed the basis for the first 950 MHz spectrometer in the world, was installed in the Rex Richards Building, Department of Biochemistry at the University of Oxford in October 2005. This was funded from the Wellcome Trust’s contribution to the Joint Infrastructure Fund. The spectrometer console was upgraded in 2015/16 with internal funding of £340K secured from the Institutional Strategic Support Fund, the John Fell Fund and Edward Penley Abraham Cephalosporin Fund. The new funding from EPSRC ensures that Oxford will continue to have a state-of-the-art ultra-high field NMR spectrometer, with only two comparable instruments currently available in the UK.







Related Information

Share This